Literature DB >> 15331700

The conserved carboxy terminus of the capsid domain of human immunodeficiency virus type 1 gag protein is important for virion assembly and release.

Daniel Melamed1, Michal Mark-Danieli, Michal Kenan-Eichler, Osnat Kraus, Asher Castiel, Nihay Laham, Tal Pupko, Fabian Glaser, Nir Ben-Tal, Eran Bacharach.   

Abstract

The retroviral Gag precursor plays an important role in the assembly of virion particles. The capsid (CA) protein of the Gag molecule makes a major contribution to this process. In the crystal structure of the free CA protein of the human immunodeficiency virus type 1 (HIV-1), 11 residues of the C terminus were found to be unstructured, and to date no information exists on the structure of these residues in the context of the Gag precursor molecule. We performed phylogenetic analysis and demonstrated a high degree of conservation of these 11 amino acids. Deletion of this cluster or introduction of various point mutations into these residues resulted in significant impairment of particle infectivity. In this cluster, two putative structural regions were identified, residues that form a hinge region (353-VGGP-356) and those that contribute to an alpha-helix (357-GHKARVL-363). Overall, mutations in these regions resulted in inhibition of virion production, but mutations in the hinge region demonstrated the most significant reduction. Although all the Gag mutants appeared to have normal Gag-Gag and Gag-RNA interactions, the hinge mutants were characterized by abnormal formation of cytoplasmic Gag complexes. Gag proteins with mutations in the hinge region demonstrated normal membrane association but aberrant rod-like membrane structures. More detailed analysis of these structures in one of the mutants demonstrated abnormal trapped Gag assemblies. These data suggest that the conserved CA C terminus is important for HIV-1 virion assembly and release and define a putative target for drug design geared to inhibit the HIV-1 assembly process. Copyright 2004 American Society for Microbiology

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15331700      PMCID: PMC514996          DOI: 10.1128/JVI.78.18.9675-9688.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  92 in total

Review 1.  HIV-1 replication.

Authors:  E O Freed
Journal:  Somat Cell Mol Genet       Date:  2001-11

Review 2.  Mechanisms of enveloped RNA virus budding.

Authors:  Owen Pornillos; Jennifer E Garrus; Wesley I Sundquist
Journal:  Trends Cell Biol       Date:  2002-12       Impact factor: 20.808

3.  Role of the C terminus Gag protein in human immunodeficiency virus type 1 virion assembly and maturation.

Authors:  X F Yu; Z Matsuda; Q C Yu; T H Lee; M Essex
Journal:  J Gen Virol       Date:  1995-12       Impact factor: 3.891

4.  Structural analysis of human immunodeficiency virus type 1 Gag protein interactions, using cysteine-specific reagents.

Authors:  J McDermott; L Farrell; R Ross; E Barklis
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

5.  Structure of the amino-terminal core domain of the HIV-1 capsid protein.

Authors:  R K Gitti; B M Lee; J Walker; M F Summers; S Yoo; W I Sundquist
Journal:  Science       Date:  1996-07-12       Impact factor: 47.728

6.  Atomic force microscopy investigation of fibroblasts infected with wild-type and mutant murine leukemia virus (MuLV).

Authors:  Yurii G Kuznetsov; Shoibal Datta; Natantara H Kothari; Aaron Greenwood; Hung Fan; Alexander McPherson
Journal:  Biophys J       Date:  2002-12       Impact factor: 4.033

7.  Characterization of deletion mutations in the capsid region of human immunodeficiency virus type 1 that affect particle formation and Gag-Pol precursor incorporation.

Authors:  N Srinivasakumar; M L Hammarskjöld; D Rekosh
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

8.  A structurally disordered region at the C terminus of capsid plays essential roles in multimerization and membrane binding of the gag protein of human immunodeficiency virus type 1.

Authors:  Chen Liang; Jing Hu; James B Whitney; Lawrence Kleiman; Mark A Wainberg
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

9.  Human immunodeficiency virus type 1 nucleocapsid zn(2+) fingers are required for efficient reverse transcription, initial integration processes, and protection of newly synthesized viral DNA.

Authors:  James S Buckman; William J Bosche; Robert J Gorelick
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

10.  The spacer peptide between human immunodeficiency virus capsid and nucleocapsid proteins is essential for ordered assembly and viral infectivity.

Authors:  H G Kräusslich; M Fäcke; A M Heuser; J Konvalinka; H Zentgraf
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

View more
  37 in total

1.  Conserved and variable features of Gag structure and arrangement in immature retrovirus particles.

Authors:  Alex de Marco; Norman E Davey; Pavel Ulbrich; Judith M Phillips; Vanda Lux; James D Riches; Tibor Fuzik; Tomas Ruml; Hans-Georg Kräusslich; Volker M Vogt; John A G Briggs
Journal:  J Virol       Date:  2010-09-01       Impact factor: 5.103

2.  Dimerization of the SP1 Region of HIV-1 Gag Induces a Helical Conformation and Association into Helical Bundles: Implications for Particle Assembly.

Authors:  Siddhartha A K Datta; Patrick K Clark; Lixin Fan; Buyong Ma; Demetria P Harvin; Raymond C Sowder; Ruth Nussinov; Yun-Xing Wang; Alan Rein
Journal:  J Virol       Date:  2015-12-04       Impact factor: 5.103

Review 3.  Novel approaches to inhibiting HIV-1 replication.

Authors:  Catherine S Adamson; Eric O Freed
Journal:  Antiviral Res       Date:  2009-09-24       Impact factor: 5.970

4.  Mutation of dileucine-like motifs in the human immunodeficiency virus type 1 capsid disrupts virus assembly, gag-gag interactions, gag-membrane binding, and virion maturation.

Authors:  Anjali Joshi; Kunio Nagashima; Eric O Freed
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

Review 5.  HIV type 1 Gag as a target for antiviral therapy.

Authors:  Abdul A Waheed; Eric O Freed
Journal:  AIDS Res Hum Retroviruses       Date:  2011-09-21       Impact factor: 2.205

6.  Identification of a novel RNA virus lethal to tilapia.

Authors:  Marina Eyngor; Rachel Zamostiano; Japhette Esther Kembou Tsofack; Asaf Berkowitz; Hillel Bercovier; Simon Tinman; Menachem Lev; Avshalom Hurvitz; Marco Galeotti; Eran Bacharach; Avi Eldar
Journal:  J Clin Microbiol       Date:  2014-09-17       Impact factor: 5.948

7.  Mobility of human immunodeficiency virus type 1 Pr55Gag in living cells.

Authors:  Candace Y Gomez; Thomas J Hope
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

8.  Packaging HIV virion components through dynamic equilibria of a human tRNA synthetase.

Authors:  Min Guo; Ryan Shapiro; Garrett M Morris; Xiang-Lei Yang; Paul Schimmel
Journal:  J Phys Chem B       Date:  2010-11-08       Impact factor: 2.991

9.  Effect of dimerizing domains and basic residues on in vitro and in vivo assembly of Mason-Pfizer monkey virus and human immunodeficiency virus.

Authors:  Karolína Bohmová; Romana Hadravová; Jitka Stokrová; Roman Tuma; Tomás Ruml; Iva Pichová; Michaela Rumlová
Journal:  J Virol       Date:  2009-12-09       Impact factor: 5.103

10.  GRL-02031, a novel nonpeptidic protease inhibitor (PI) containing a stereochemically defined fused cyclopentanyltetrahydrofuran potent against multi-PI-resistant human immunodeficiency virus type 1 in vitro.

Authors:  Yasuhiro Koh; Debananda Das; Sofiya Leschenko; Hirotomo Nakata; Hiromi Ogata-Aoki; Masayuki Amano; Maki Nakayama; Arun K Ghosh; Hiroaki Mitsuya
Journal:  Antimicrob Agents Chemother       Date:  2008-10-27       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.